Markets
Security | Price | % | Buy | Sell | Target price ▼ | Potential |
---|---|---|---|---|---|---|
Racipharm AB B |
€22.28
04.03.21 |
-1.070% | 0 | 0 | - | - |
Hepion Pharmaceuticals Inc. |
€9.20
09.02.24 |
- | 0 | 0 | - | - |
Cymabay Therapeutics Inc |
€30.00
03.04.24 |
- | 0 | 0 | - | - |
Biodelivery Sciences |
€5.05
22.03.22 |
-0.980% | 0 | 0 | - | - |
Aveo Pharmaceuticals Inc. |
€13.85
19.01.23 |
-1.910% | 0 | 0 | - | - |
Auscann Group Holdings Ltd |
€0.028
12.11.23 |
-10.170% | 0 | 0 | - | - |
Nymox Pharmaceutical Corp. |
€0.23
06.07.23 |
5.410% | 0 | 0 | - | - |
Universal Health Intl Group Holding Ltd |
€0.002
11.12.20 |
100.000% | 0 | 0 | - | - |
Recro Pharma Inc. |
€1.70
04.02.23 |
- | 0 | 0 | - | - |
Assembly Biosciences Inc. |
€0.93
09.02.24 |
3.990% | 0 | 0 | - | - |
Polynovo Ltd |
€1.61
01.08.24 |
2.550% | 1 | 0 | - | - |
Erytech Pharma S.A. |
€0.39
15.09.23 |
-5.170% | 0 | 0 | - | - |
OncoCyte Corp |
€0.18
12.11.23 |
-3.610% | 0 | 0 | - | - |
Grindeks AS |
€9.96
22.02.21 |
7.330% | 0 | 0 | - | - |
Kiadis Pharma Bv |
€5.43
21.05.21 |
0.370% | 0 | 0 | - | - |
Acorda Therapeutics Cdt |
€0.47
02.06.23 |
-2.970% | 10 | 0 | - | - |
CorMedix Inc |
€4.06
01.08.24 |
-2.870% | 0 | 0 | - | - |
Osmotica Pharmaceuticals PLC |
€0.15
20.11.23 |
8.780% | 0 | 0 | - | - |
Chugai Pharmaceutical Co Ltd |
€38.93
22:26 |
0.720% | 0 | 0 | - | - |
Boiron S.A. |
€32.15
01.08.24 |
-0.160% | 0 | 0 | - | - |
PLX Pharma Inc |
€0.006
15.06.23 |
- | 0 | 0 | - | - |
Infinity Pharmaceuticals Inc. |
€0.19
09.10.23 |
7.360% | 0 | 0 | - | - |
Zogenix Inc. |
€24.39
11.06.22 |
- | 0 | 0 | - | - |
Motif Bio plc |
€0.66
15.06.21 |
- | 0 | 0 | - | - |
Acelrx Pharmaceuticals Inc. |
€0.86
01.08.24 |
-4.650% | 0 | 0 | - | - |
Clinigen Group plc |
€10.70
04.04.22 |
- | 0 | 0 | - | - |
Kyowa Hakko Kirin Co. Ltd. |
€18.80
01.08.24 |
-1.570% | 0 | 0 | - | - |
Chemocentryx Inc. |
€53.25
19.10.22 |
0.570% | 0 | 0 | - | - |
Minerva Neurosciences Inc. |
€2.76
01.08.24 |
0.730% | 0 | 9 | - | - |
Genocea Biosciences Inc. |
€0.009
23.12.22 |
- | 1 | 21 | - | - |